Skip to main content
OpenTrials

Clinical trial condition

Stage II Pancreatic Cancer AJCC v8

Explore clinical trials studying Stage II Pancreatic Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

25 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Stage II Pancreatic Cancer AJCC v8 trial results

Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT06958328

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States
View all 322 locations
View Trial Details
Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971

Conditions
Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

NCT06906562

Conditions
Advanced Pancreatic Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Ohio State University-Telemedicine Birmingham, Alabama, United States
  • Ohio State University-Telemedicine Mobile, Alabama, United States
  • Ohio State University Telemedicine Montgomery, Alabama, United States
  • Ohio State University-Telemedicine Anchorage, Alaska, United States
View all 109 locations
View Trial Details
Active, not recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Conditions
Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details

Related conditions